Sign in / Join Now
ETFs & Funds
making a comeback?
Excellent drug prospects, long term play
played 3 times for $$ now long to ph3 runup
Add a reply...
Latest StockTalks »
people get MSTX breaking news and analysis by email alert.
Get email alerts on MSTX »
Mast Therapeutics, Inc.
Get latest price
From other sites
Mast Therapeutics Provides Clinical Developments Update; Range-Bound Trading A Mid-Term Plausibility
at Benzinga (Tue, 10:57AM)
Mast Therapeutics Provides Business Update
at TheStreet (Mon, 9:00AM)
Mast Therapeutics Crash Led By Poor Results (MSTX)
at Investopedia (Sep 21, 2016)
Mid-Day Market Update: Crude Oil Up 2.75%; Mast Therapeutics Shares Drop After Sickle Cell Drug Phase 3 Trial Fail
at Benzinga (Sep 21, 2016)
Shkreli Warned You: Mast Therapeutics Plummets 80% After Sickle Cell Drug Phase 3 Trial Fail
at Benzinga (Sep 20, 2016)